A Gene-Expression Signature as a Predictor of Survival in Breast CancerMarc J. van de Vijver, René Bernards, Yudong D. He et al.|New England Journal of Medicine|2002Cited by 6.5k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast CancerFátima Cardoso, Martine Piccart, Laura J. van’t Veer et al.|New England Journal of Medicine|2016Cited by 2k
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal CancerRamón Salazar, Rob A.�E.�M. Tollenaar, Hans Morreau et al.|Journal of Clinical Oncology|2010Cited by 540
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by ageMartine Piccart, Emiel J. Rutgers, Laura van ‘t Veer et al.|The Lancet Oncology|2021Cited by 355
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)Jolien M. Bueno-de-Mesquita, Sabine C. Linn, Wim H. van Harten et al.|The Lancet Oncology|2007Cited by 278